These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4088201)

  • 21. Prolonged retention in the circulation of emulsified lipid-coated perfluorochemicals.
    Sloviter HA; Mukherji B
    Prog Clin Biol Res; 1983; 122():181-7. PubMed ID: 6878359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of postischemic reperfusion cardiac injury with a perfluorochemical solution.
    Parrish MD; Olson RD; Mushlin PS; Artman M; Boucek RJ
    J Cardiovasc Pharmacol; 1984; 6(1):159-64. PubMed ID: 6199599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of fetal exchange transfusion with a red blood cell substitute.
    Ambrose A; Cefalo RC; Bowes WA
    Am J Obstet Gynecol; 1986 Mar; 154(3):667-74. PubMed ID: 3082209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of new methods in suppressing brain infarction--combined administration of mannitol and perfluorochemicals (author's transl)].
    Suzuki J; Yoshimoto T; Tanaka S; Mizoi K; Kagawa S
    Hokkaido Igaku Zasshi; 1981 Jul; 56(4):367-73. PubMed ID: 6799378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research progress of blood substitutes for the treatment of hemorrhagic shock].
    Song J; Wang X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):453-7. PubMed ID: 20481338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Refractive index and thickness of the outer layer of particles of dispersed perfluorochemical-based blood substitutes].
    Kuznetsova IN; Bezrukova AG; Lopatin VN; Parshin AV
    Biofizika; 1988; 33(1):126-9. PubMed ID: 3370229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Perfluorochemicals as artificial blood. problems and actual development (author's transl)].
    Schnoy N; Pfannkuch F; Beisbarth H
    Anaesthesist; 1979 Nov; 28(11):503-10. PubMed ID: 118676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Possibility of the use of perfluorochemicals (fluorocarbons) as adjuvants in chemotherapy of cancer].
    Kuwamura K; Kokunai T
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1256-61. PubMed ID: 7184453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gas exchange and blood circulation status in dogs following replacement of acute blood loss by perfluoro compound emulsions].
    Akhsianov UU; Afonin NI; Troitskiĭ VB; Sukiasian GV; Karpov AP
    Biull Eksp Biol Med; 1983 Sep; 96(9):21-3. PubMed ID: 6616046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perfluorochemical-based artificial oxygen carrying red cell substitutes.
    Lane TA
    Transfus Sci; 1995 Mar; 16(1):19-31. PubMed ID: 10155703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.
    Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.
    Oda Y; Handa H; Nagasawa S; Naruo Y; Asato R; Yonekawa Y
    Neurol Res; 1982; 4(1-2):35-45. PubMed ID: 6127644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%). Part II: Human cerebral blood flow.
    Nagasawa S; Handa H; Yonekawa Y; Oda Y; Tsuda Y; Yokoyama K
    Neurol Res; 1983; 5(2):19-30. PubMed ID: 6140661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s.
    Spence RK; Norcross ED; Costabile J; McCoy S; Cernaianu AC; Alexander JB; Pello MJ; Atabek U; Camishion RC
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):955-63. PubMed ID: 7849967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases.
    Mitsuno T; Ohyanagi H; Naito R
    Ann Surg; 1982 Jan; 195(1):60-9. PubMed ID: 7034658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (Pyridoxylated hemoglobin)-(polyoxyethylene) conjugate solution as blood substitute for normothermic whole body rinse-out.
    Agishi T; Funakoshi Y; Honda H; Yamagata K; Kobayashi M; Takahashi M
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):261-70. PubMed ID: 3179468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study.
    Kagawa S; Koshu K; Yoshimoto T; Suzuki J
    Surg Neurol; 1982 Jan; 17(1):66-70. PubMed ID: 6803373
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical oxygen transport using perfluorochemicals.
    Kaufman RJ
    Biotechnology; 1991; 19():127-62. PubMed ID: 1786469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.